tradingkey.logo

Embecta Corp

EMBC

10.000USD

+0.040+0.40%
交易中 美东报价延迟15分钟
583.28M总市值
11.05市盈率 TTM

Embecta Corp

10.000

+0.040+0.40%
关于 Embecta Corp 公司
Embecta Corp. 是一家全球医疗器械公司,专注于提供改善糖尿病患者健康和福祉的解决方案。该公司拥有一系列营销产品,包括各种笔式针头、注射器和安全注射装置。其笔式针头是无菌、一次性医疗器械,旨在与注射胰岛素或其他糖尿病药物的笔式注射器配合使用。该公司还销售安全笔式针头,这种针头在套管两端都有护罩,可在注射后自动展开,有助于防止注射和处置过程中针刺暴露和受伤。其传统和安全笔式针头与市场上的笔式注射器兼容且经常使用。该公司销售无菌、一次性胰岛素注射器,用于注射从胰岛素瓶中抽取的胰岛素。该公司还销售安全胰岛素注射器。该公司通过各种渠道分销其产品,包括零售、医院和药店。
公司简介
公司代码EMBC
公司名称Embecta Corp
上市日期Mar 21, 2022
CEOMr. Devdatt (Dev) Kurdikar
员工数量2100
证券类型Ordinary Share
年结日Mar 21
公司地址300 Kimball Drive
城市PARSIPPANY
上市交易所NASDAQ Global Select Consolidated
国家United States of America
邮编07054
电话18624010000
网址https://www.embecta.com/
公司代码EMBC
上市日期Mar 21, 2022
CEOMr. Devdatt (Dev) Kurdikar
公司高管
名称
名称/职务
职务
持股
持股变动
Lt. Gen. David F. Melcher
Lt. Gen. David F. Melcher
Non-Executive Independent Chairman of the Board
Non-Executive Independent Chairman of the Board
70.64K
+16.49%
Mr. Christopher R. (Chris) Reidy
Mr. Christopher R. (Chris) Reidy
Director
Director
33.26K
+71.26%
Mr. Robert J. (Bob) Hombach, CPA
Mr. Robert J. (Bob) Hombach, CPA
Independent Director
Independent Director
27.73K
+99.66%
Ms. Carrie L. Anderson
Ms. Carrie L. Anderson
Independent Director
Independent Director
27.72K
+99.70%
Dr. Milton Mayo Morris, Ph.D.
Dr. Milton Mayo Morris, Ph.D.
Independent Director
Independent Director
24.21K
+79.71%
Mr. Devdatt (Dev) Kurdikar
Mr. Devdatt (Dev) Kurdikar
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
21.63K
-64.67%
Mr. Jacob (Jake) Elguicze
Mr. Jacob (Jake) Elguicze
Chief Financial Officer, Senior Vice President
Chief Financial Officer, Senior Vice President
15.83K
-23.81%
Mr. Jeffrey Z. (Jeff) Mann
Mr. Jeffrey Z. (Jeff) Mann
Senior Vice President, General Counsel, Head of Corporate Development, and Corporate Secretary
Senior Vice President, General Counsel, Head of Corporate Development, and Corporate Secretary
11.05K
-32.36%
Mr. Shaun Curtis
Mr. Shaun Curtis
Senior Vice President - Global Manufacturing and Supply Chain
Senior Vice President - Global Manufacturing and Supply Chain
6.57K
-33.10%
Ms. Jean Casner
Ms. Jean Casner
Chief Human Resources Officer, Senior Vice President
Chief Human Resources Officer, Senior Vice President
2.87K
-93.98%
查看更多
名称
名称/职务
职务
持股
持股变动
Lt. Gen. David F. Melcher
Lt. Gen. David F. Melcher
Non-Executive Independent Chairman of the Board
Non-Executive Independent Chairman of the Board
70.64K
+16.49%
Mr. Christopher R. (Chris) Reidy
Mr. Christopher R. (Chris) Reidy
Director
Director
33.26K
+71.26%
Mr. Robert J. (Bob) Hombach, CPA
Mr. Robert J. (Bob) Hombach, CPA
Independent Director
Independent Director
27.73K
+99.66%
Ms. Carrie L. Anderson
Ms. Carrie L. Anderson
Independent Director
Independent Director
27.72K
+99.70%
Dr. Milton Mayo Morris, Ph.D.
Dr. Milton Mayo Morris, Ph.D.
Independent Director
Independent Director
24.21K
+79.71%
Mr. Devdatt (Dev) Kurdikar
Mr. Devdatt (Dev) Kurdikar
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
21.63K
-64.67%
收入明细
单位: USD更新时间: 7月6日 周日
单位: USD更新时间: 7月6日 周日
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2021
FY2020
FY2019
业务USD
名称
营收
占比
Pen Needles
188.30M
72.70%
Safety
34.20M
13.20%
Syringes
28.80M
11.12%
Manufacturing Facility
4.40M
1.70%
Other
3.30M
1.27%
地区USD
名称
营收
占比
United States
135.20M
52.20%
International
123.80M
47.80%
业务
地区
业务USD
名称
营收
占比
Pen Needles
188.30M
72.70%
Safety
34.20M
13.20%
Syringes
28.80M
11.12%
Manufacturing Facility
4.40M
1.70%
Other
3.30M
1.27%
股东统计
更新时间: 5月16日 周五
更新时间: 5月16日 周五
持股股东
股东类型
持股股东
持股股东
占比
BlackRock Institutional Trust Company, N.A.
14.22%
The Vanguard Group, Inc.
9.35%
American Century Investment Management, Inc.
6.53%
River Road Asset Management, LLC
5.52%
Deerfield Management Company, L.P.
4.66%
Other
59.72%
持股股东
持股股东
占比
BlackRock Institutional Trust Company, N.A.
14.22%
The Vanguard Group, Inc.
9.35%
American Century Investment Management, Inc.
6.53%
River Road Asset Management, LLC
5.52%
Deerfield Management Company, L.P.
4.66%
Other
59.72%
股东类型
持股股东
占比
Investment Advisor
47.25%
Investment Advisor/Hedge Fund
31.40%
Hedge Fund
14.81%
Research Firm
3.39%
Pension Fund
1.88%
Individual Investor
0.58%
Bank and Trust
0.47%
Family Office
0.39%
Sovereign Wealth Fund
0.20%
机构持股
更新时间: 7月1日 周二
更新时间: 7月1日 周二
报告期
机构数
持股数
持股占比
持股变动
2025Q2
807
58.42M
99.96%
-4.71M
2025Q1
870
59.92M
102.54%
-2.68M
2024Q4
896
57.53M
98.96%
-4.74M
2024Q3
920
56.50M
97.90%
-9.87M
2024Q2
984
57.71M
100.06%
-7.71M
2024Q1
1015
57.41M
99.70%
-8.13M
2023Q4
1024
56.86M
98.76%
-5.95M
2023Q3
991
57.96M
101.15%
-3.68M
2023Q2
973
55.10M
96.16%
-6.57M
2023Q1
941
56.77M
99.09%
-4.50M
查看更多
股东持股明细
名称
持股数
占比
持股变动
变动比例
公告日期
BlackRock Institutional Trust Company, N.A.
8.31M
14.22%
-119.26K
-1.41%
Mar 31, 2025
The Vanguard Group, Inc.
6.67M
11.42%
-311.93K
-4.47%
Mar 31, 2025
American Century Investment Management, Inc.
3.81M
6.53%
+551.48K
+16.91%
Mar 31, 2025
River Road Asset Management, LLC
3.23M
5.52%
-19.50K
-0.60%
Mar 31, 2025
Deerfield Management Company, L.P.
2.72M
4.66%
-550.00K
-16.82%
Mar 31, 2025
State Street Global Advisors (US)
2.38M
4.08%
+15.67K
+0.66%
Mar 31, 2025
Yacktman Asset Management LP
2.36M
4.03%
-25.71K
-1.08%
Mar 31, 2025
William Blair Investment Management, LLC
1.98M
3.39%
+1.24M
+167.54%
Mar 31, 2025
Geode Capital Management, L.L.C.
1.47M
2.51%
+83.34K
+6.02%
Mar 31, 2025
Sio Capital Management, LLC
1.11M
1.9%
+682.04K
+160.26%
Mar 31, 2025
查看更多
持股ETF
更新时间: 8月2日 周六
更新时间: 8月2日 周六
机构名称
占比
SPDR S&P Health Care Equipment ETF
1%
Lattice Hartford Multifactor Small Cap ETF
0.62%
Invesco S&P Spin-Off ETF
0.56%
Invesco NASDAQ Future Gen 200 ETF
0.41%
Invesco S&P SmallCap Health Care ETF
0.41%
Global X Aging Population ETF
0.22%
VictoryShares Hedged Equity Income ETF
0.2%
Inspire Small/Mid Cap ESG ETF
0.15%
WisdomTree US SmallCap Fund
0.11%
Vanguard US Multifactor ETF
0.11%
查看更多
SPDR S&P Health Care Equipment ETF
占比1%
Lattice Hartford Multifactor Small Cap ETF
占比0.62%
Invesco S&P Spin-Off ETF
占比0.56%
Invesco NASDAQ Future Gen 200 ETF
占比0.41%
Invesco S&P SmallCap Health Care ETF
占比0.41%
Global X Aging Population ETF
占比0.22%
VictoryShares Hedged Equity Income ETF
占比0.2%
Inspire Small/Mid Cap ESG ETF
占比0.15%
WisdomTree US SmallCap Fund
占比0.11%
Vanguard US Multifactor ETF
占比0.11%
分红派息
近5年累计派现 77.50M 美元
公告日期
分红计划
股权登记日
现金发放日
除权除息日
Feb 06, 2025
EMBC.NB Interim Cash Dividend of gross USD 0.15 paid on Mar 14, 2025 going ex on Feb 28, 2025
Feb 28, 2025
Mar 14, 2025
Feb 28, 2025
Nov 26, 2024
EMBC.NB Interim Cash Dividend of gross USD 0.15 paid on Dec 18, 2024 going ex on Dec 06, 2024
Dec 06, 2024
Dec 18, 2024
Dec 06, 2024
Aug 09, 2024
EMBC.NB Interim Cash Dividend of gross USD 0.15 paid on Sep 13, 2024 going ex on Aug 27, 2024
Aug 27, 2024
Sep 13, 2024
Aug 27, 2024
May 09, 2024
EMBC.NB Final Cash Dividend of gross USD 0.15 paid on Jun 14, 2024 going ex on May 24, 2024
May 28, 2024
Jun 14, 2024
May 24, 2024
Feb 09, 2024
EMBC.NB Interim Cash Dividend of gross USD 0.15 paid on Mar 15, 2024 going ex on Feb 27, 2024
Feb 28, 2024
Mar 15, 2024
Feb 27, 2024
Nov 21, 2023
EMBC.NB Interim Cash Dividend of gross USD 0.15 paid on Dec 15, 2023 going ex on Dec 01, 2023
Dec 04, 2023
Dec 15, 2023
Dec 01, 2023
Aug 08, 2023
EMBC.NB Interim Cash Dividend of gross USD 0.15 paid on Sep 13, 2023 going ex on Aug 24, 2023
Aug 25, 2023
Sep 13, 2023
Aug 24, 2023
May 12, 2023
EMBC.NB Final Cash Dividend of gross USD 0.15 paid on Jun 13, 2023 going ex on May 25, 2023
May 29, 2023
Jun 13, 2023
May 25, 2023
Feb 14, 2023
EMBC.NB Interim Cash Dividend of gross USD 0.15 paid on Mar 13, 2023 going ex on Feb 24, 2023
Feb 27, 2023
Mar 13, 2023
Feb 24, 2023
Dec 20, 2022
EMBC.NB Interim Cash Dividend of gross USD 0.15 paid on Jan 11, 2023 going ex on Dec 29, 2022
Dec 30, 2022
Jan 11, 2023
Dec 29, 2022
查看更多
拆合股
公告日期
类型
比率
暂无数据
公告日期
类型
比率
暂无数据
tradingkey.logo
tradingkey.logo
日内数据由路孚特(Refinitiv)提供,并受使用条款约束。历史及当前收盘数据均由路孚特提供。所有报价均以当地交易所时间为准。美股报价的实时最后成交数据仅反映通过纳斯达克报告的交易。日内数据延迟至少15分钟或遵循交易所要求。
* 参考、分析和交易策略由第三方提供商Trading Central提供,观点基于分析师的独立评估和判断,未考虑投资者的投资目标和财务状况。
风险提示:我们的网站和移动应用程序仅提供关于某些投资产品的一般信息。Finsights 不提供财务建议或对任何投资产品的推荐,且提供此类信息不应被解释为 Finsights 提供财务建议或推荐。
投资产品存在重大投资风险,包括可能损失投资的本金,且可能并不适合所有人。投资产品的过去表现并不代表其未来表现。
Finsights 可能允许第三方广告商或关联公司在我们的网站或移动应用程序的任何部分放置或投放广告,并可能根据您与广告的互动情况获得报酬。
© 版权所有: FINSIGHTS MEDIA PTE. LTD. 版权所有
KeyAI